Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO)

Background:  Dengue is a disease of major global importance. While most symptomatic infections are mild, a small proportion of patients progress to severe disease with risk of hypovolaemic shock, organ dysfunction and death.  In the absence of effective antiviral or disease modifying drugs, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Nguyet Minh, Chanh, Ho Quang, Tam, Dong Thi Hoai, Vuong, Nguyen Lam, Chau, Nguyen Thi Xuan, Chau, Nguyen Van Vinh, Phong, Nguyen Thanh, Trieu, Huynh Trung, Luong Thi Hue, Tai, Cao Thi, Tam, Dinh The, Trung, Duyen, Huynh Thi Le, Van, Ninh Thi Thanh, Nguyen Than Ha, Quyen, Rivino, Laura, Gallagher, Peter, Jones, Nick K., Geskus, Ronald B., Kestelyn, Evelyne, Yacoub, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539082/
https://www.ncbi.nlm.nih.gov/pubmed/33083561
http://dx.doi.org/10.12688/wellcomeopenres.16053.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539082/
https://www.ncbi.nlm.nih.gov/pubmed/33083561
http://dx.doi.org/10.12688/wellcomeopenres.16053.2

Ejemplares similares